To describe the incidence, risk factors and maternal and perinatal mortality and severe morbidity among women with HELLP syndrome. STUDY DESIGN: We carried out a population-based cohort study of all women with a singleton birth in Canada (excl. Quebec), 2012-2015 (N¼1,078,323). Demographic characteristics, HELLP syndrome, and associated neonatal and maternal morbidity were identified from delivery hospitalization data (including diagnostic/ procedure codes). The primary outcomes were composite mortality/severe morbidity, including death and other severe morbidity in the mother (e.g., shock, obstetric embolism, cardiac arrest) and the infant (e.g., intraventricular hemorrhage, sepsis). Logistic regression was used to obtain adjusted odds ratios (AOR) and 95% confidence intervals (CI) after adjustment for maternal age, socioeconomic status (SES), rural/urban residence, pre-pregnancy morbidity, and other factors. RESULTS: The incidence of HELLP syndrome (n¼2663) was 24.7 per 10,000 births, while the rates of severe preeclampsia and eclampsia were 23.5 and 4.31 per 10,000 births, respectively. Rates increased with gestational age (Fig 1) . HELLP syndrome was associated with high SES, rural residence, obesity, excess pregnancy weight gain, nulliparity, chronic hypertension and diabetes, gestational diabetes, gestational hypertension, lupus erythematosus, placental disorders, breech/oblique presentation, use of assisted reproduction and congenital anomalies. Women with HELLP had elevated mortality (AOR¼7.64, CI 1.02-57.39) and mortality/ severe morbidity (AOR¼7.70, CI 6.87-8.63). Their rates of perinatal mortality and neonatal mortality/severe morbidity were also increased (AOR¼4.37, CI 2.73-6.98 and AOR¼12.10, CI 10.89-13.45; respectively). CONCLUSION: HELLP syndrome incidence increases with increasing gestational age, is associated with specific pre-pregnancy and pregnancy risk factors and results in substantially higher rates of maternal and perinatal mortality and severe morbidity.
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